Stay updated with breaking news from Mark Bleackley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Final results are in for a Phase 1 clinical trial to assess pharmacokinetics and the safety of Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)’s...
MELBOURNE, Australia, May 02, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has engaged Catalent Pharma Solutions for the development and cGMP manufacture of its psilocybin drug...
Highlights: Incannex has engaged Catalent for the development and cGMP manufacture of Incannex’s own psilocybin drug product.The psilocybin is designed...
Highlights: Incannex has commenced a Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Safety and Effect on Pain and Function of...